Skip to main content

HIDROGELES ACTIVOS ACTUADOS POR POLIMEROS BIOLOGICOS VIVOS: MECANICA Y DINAMICA DE LAS PROTEINAS FUERA Y DENTRO DEL HIDROGEL

FIS2015-70339-C2-2-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Translation elongation factor eEF1A2 is a novel anticancer target for the marine natural product plitidepsin

  • Losada, A.
  • Muñoz-Alonso, María J.
  • García Rodríguez, Carolina
  • Sánchez-Murcia, Pedro A.
  • Martínez-Leal, Juan Fernando
  • Domínguez, J.M.
  • Lillo, M. Pilar
  • Gago, Federico
  • Galmarini, C.M.
eEF1A2 is one of the isoforms of the alpha subunit of the eukaryotic Elongation Factor 1. It is overexpressed in human tumors and is endowed with oncogenic properties, favoring tumor cell proliferation while inhibiting apoptosis. We demonstrate that plitidepsin, an antitumor agent of marine origin that has successfully completed a phase-III clinical trial for multiple myeloma, exerts its antitumor activity by targeting eEF1A2. The drug interacts with eEF1A2 with a K D of 80 nM and a target residence time of circa 9 min. This protein was also identified as capable of binding [ 14 C]-plitidepsin in a cell lysate from K-562 tumor cells. A molecular modelling approach was used to identify a favorable binding site for plitidepsin at the interface between domains 1 and 2 of eEF1A2 in the GTP conformation. Three tumor cell lines selected for at least 100-fold more resistance to plitidepsin than their respective parental cells showed reduced levels of eEF1A2 protein. Ectopic expression of eEF1A2 in resistant cells restored the sensitivity to plitidepsin. FLIM-phasor FRET experiments demonstrated that plitidepsin localizes in tumor cells sufficiently close to eEF1A2 as to suggest the formation of drug-protein complexes in living cells. Altogether, our results strongly suggest that eEF1A2 is the primary target of plitidepsin., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dynamic cellular maps of molecular species: Application to drug-target interactions

  • García Rodríguez, Carolina
  • Losada, A.
  • Sacristán, M.A.
  • Martínez-Leal, Juan Fernando
  • Galmarini, C.M.
  • Lillo, M. Pilar
The design of living cell studies aimed at deciphering the mechanism of action of drugs targeting proteins with multiple functions, expressed in a wide range of concentrations and cellular locations, is a real challenge. We recently showed that the antitumor drug plitidepsin (APL) localizes sufficiently close to the elongation factor eEF1A2 so as to suggest the formation of drug-protein complexes in living cells. Here we present an extension of our previous micro-spectroscopy study, that combines Generalized Polarization (GP) images, with the phasor approach and fluorescence lifetime imaging microscopy (FLIM), using a 7-aminocoumarin drug analog (APL) as fluorescence tracer. Using the proposed methodology, we were able to follow in real time the formation and relative distribution of two sets of APL-target complexes in live cells, revealing two distinct patterns of behavior for HeLa-wt and APL resistant HeLa-APL-R cells. The information obtained may complement and facilitate the design of new experiments and the global interpretation of the results obtained with other biochemical and cell biology methods, as well as possibly opening new avenues of study to decipher the mechanism of action of new drugs., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Surface orientation and binding strength modulate shape of FtsZ on lipid surfaces

  • Márquez, Ileana F.
  • Díaz-Haro, Gabriel
  • Vélez, Marisela
© The Author(s)., We have used a simple model system to test the prediction that surface attachment strength of filaments presenting a torsion would affect their shape and properties. FtsZ from E. coli containing one cysteine in position 2 was covalently attached to a lipid bilayer containing maleimide lipids either in their head group (to simulate tight attachment) or at the end of a polyethylene glycol molecule attached to the head group (to simulate loose binding). We found that filaments tightly attached grew straight, growing from both ends, until they formed a two-dimensional lattice. Further monomer additions to their sides generated a dense layer of oriented filaments that fully covered the lipid membrane. After this point the surface became unstable and the bilayer detached from the surface. Filaments with a loose binding were initially curved and later evolved into straight thicker bundles that destabilized the membrane after reaching a certain surface density. Previously described theoretical models of FtsZ filament assembly on surfaces that include lateral interactions, spontaneous curvature, torsion, anchoring to the membrane, relative geometry of the surface and the filament ‘living-polymer’ condition in the presence of guanosine triphosphate (GTP) can offer some clues about the driving forces inducing these filament rearrangements, Financial support is acknowledged to project FIS2015–70339-C2–2-R from the Spanish Ministry of Science and Innovation and project SINOXPHOS-CM - S2018/BAA-4403 from the Comunidad Autónoma de Madrid (CAM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy

  • González Rubio, Sergio
  • Montero Pastor, Nuria
  • García Rodríguez, Carolina
  • Almendro-Vedia, V.G.
  • Ferrer, Irene
  • Natale, Paolo
  • Paz-Ares, Luis
  • Lillo, M. Pilar
  • López-Montero, Iván
8 pags, 5 figs, Cancer cell mitochondria represent an attractive target for oncological treatment as they have unique hallmarks that differ from their healthy counterparts, as the presence of a stronger membrane potential that can be exploited to specifically accumulate cytotoxic cationic molecules. Here, we explore the selective cytotoxic effect of 10-N-nonyl acridine orange (NAO) on human lung carcinoma H520 cells and compare them with healthy human lung primary fibroblasts. NAO is a lipophilic and positively charged molecule that promotes mitochondrial membrane adhesion that eventually leads to apoptosis when incubated at high micromolar concentration. We found an enhanced cytotoxicity of NAO in H520 cancer cells. By means Fluorescence lifetime imaging microscopy (FLIM) we also confirmed the formation of H-dimeric aggregates originating fromopposing adjacent membranes that interfere with the mitochondrial membrane structure. Based on our results, we suggest the mitochondrial membrane as a potential target in cancer therapy to mechanically control the cell proliferation of cancer cells., This work was supported by the ERC Starting Grant MITOCHON (ERC-StG-2013-338133), ERC Proof of Concept mitozippers (ERC-PoC-2017-780440) and FIS2015-70339-C2-1-R from the Spanish Ministry of Economy MINECO (IL-M); and FIS2015-70339-C2-2-R (MPL and CG).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Using laurdan and spectral phasor analysis to study erythrocytes membrane solubilization

  • Sanchez, Susana A.
  • Herlax, Vanesa
  • Lillo, M. Pilar
  • Sandoval, Catalina
  • Aguilar, Joao
  • Gunther, German
1 pag. -- 62nd Annual Meeting of the Biophysical-Society, San Francisco, California, February 17-21, 2018, Fondecyt #1140454 (S.S.), Fondecyt #1080412 (G.G.), Beca de Doctorado Conicyt (C.S.). PICT 2657/2013 (VH). # FIS2015-70339-C2-2-R (M.P.L.). LFD (8P41GM103540)., Peer reviewed